Safety and feasibility of chimeric antigen receptor T cell therapy after allogeneic hematopoietic cell transplantation in relapsed/ refractory B cell non-Hodgkin lymphoma
2019
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
16
References
17
Citations
NaN
KQI